CAS: 1346602-17-2

2’-Oxo tadalafil is a synthetic compound, specifically a derivative of tadalafil. It is a research chemical derived from chemical modifications and is closely related to phosphodiesterase type 5 (PDE5) inhibitors. Its mode of action involves the inhibition of the PDE5 enzyme, leading to increased levels of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the corpus cavernosum. This action facilitates smooth muscle relaxation and increased blood flow, which are key mechanisms in the treatment of erectile dysfunction. The primary use of 2’-Oxo tadalafil is in scientific research focused on understanding the biochemical pathways and pharmacological profiles of PDE5 inhibitors. It serves as a valuable compound for studies investigating the structural-activity relationships of similar therapeutic agents. Furthermore, its applications extend to exploring improved formulations or modifications that could enhance efficacy or reduce side effects in clinical settings. As such, this compound is a crucial tool for scientists aiming to innovate and optimize treatments for conditions related to PDE5 dysfunction.